Alcohol and high-density-lipoprotein cholesterol: a randomized controlled trial.

Area of Science:

• Cardiology
• Nutritional Science
• Epidemiology

Background:

• Ischaemic heart disease remains a leading cause of mortality worldwide.
• The role of moderate alcohol consumption in cardiovascular health is a subject of ongoing research and debate.
• Understanding the impact of alcohol on specific biomarkers is crucial for risk assessment.

Purpose of the Study:

• To investigate the effects of moderate alcohol consumption on blood lipid profiles.
• To assess the influence of alcohol on haematological factors associated with ischaemic heart disease.
• To evaluate the potential cardioprotective hypothesis linked to alcohol intake.

Main Methods:

• A randomized controlled trial with a cross-over design was employed.
• One hundred participants consumed alcohol (mean 18.4 g/d) for 4 weeks, followed by a 4-week abstinence period, with randomized order.
• Serum lipids, including high-density-lipoprotein (HDL) cholesterol and its subfractions, were analyzed.

Main Results:

• A statistically significant increase of 7% in serum HDL cholesterol was observed during alcohol consumption.
• This rise in HDL cholesterol was primarily attributed to an increase in the HDL2 subfraction.
• No significant alterations were found in plasma fibrinogen levels or other examined haematological indices.

Conclusions:

• Moderate alcohol intake may positively influence lipid profiles by elevating HDL cholesterol.
• The findings support the hypothesis that moderate alcohol consumption could offer a degree of protection against ischaemic heart disease.
• Further research is warranted to elucidate the mechanisms and confirm the long-term cardiovascular benefits.